Details of the Drug

General Information of Drug (ID: DMOCG6M)

• Drug Name: Pyridin-3-yl 4-butoxybenzylcarbamate
• Synonyms: CHEMBL596877; pyridin-3-yl 4-butoxybenzylcarbamate

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 300.35
  Logarithm of the Partition Coefficient (xlogp); 3.1
  Rotatable Bond Count (rotbonds); 8
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C17H20N2O3
  IUPAC Name: pyridin-3-yl N-[(4-butoxyphenyl)methyl]carbamate
  Canonical SMILES: CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CN=CC=C2
  InChI: InChI=1S/C17H20N2O3/c1-2-3-11-21-15-8-6-14(7-9-15)12-19-17(20)22-16-5-4-10-18-13-16/h4-10,13H,2-3,11-12H2,1H3,(H,19,20)
  InChIKey: CZFYUEMAFQHRFG-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 20872734
  TTD ID: D03SUI

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.